Literature DB >> 2362916

Stereochemical characterization of the diastereomers of the phenobarbital N-beta-D-glucose conjugate excreted in human urine.

W H Soine1, P J Soine, S E Mongrain, T M England.   

Abstract

The absolute configuration of the N-beta-D-glucoside metabolites of phenobarbital was determined by methylation of the diastereomers to make mephobarbital N-beta-D-glucosides, followed by oxidative removal of glucose to give the optical isomers of mephobarbital. Following a single oral dose of phenobarbital to two male subjects, both phenobarbital N-beta-D-glucosides were excreted in the urine. The absolute configuration (C-5 position) of the major phenobarbital N-beta-D-glucoside excreted in the urine was the S form. A pronounced stereoselective formation and/or urinary excretion occurs for the N-glucoside conjugates of phenobarbital in humans.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2362916     DOI: 10.1023/a:1015831725205

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  23 in total

1.  Ethyl (3-hydroxyisoamyl) barbituric acid as the principal metabolite of amytal.

Authors:  E W MAYNERT
Journal:  J Biol Chem       Date:  1952-03       Impact factor: 5.157

2.  Amobarbital metabolism in man. Determination of N-hydroxyamobarbital and 3'-hydroxyamobarbital in urine by gas chromatography chemical ionization mass spectrometry.

Authors:  B K Tang; T Inaba; W Kalow
Journal:  Biomed Mass Spectrom       Date:  1977-04

3.  [Absolute configuration of some C-5 disubstituted 1-methylbarbituric acids and of their degradation products].

Authors:  J Knabe; H Junginger; W Geismar
Journal:  Justus Liebigs Ann Chem       Date:  1970

4.  Quantitative determination of primidone in biological material.

Authors:  M T Bush; E Helman
Journal:  Life Sci       Date:  1965-07       Impact factor: 5.037

5.  Enantioselective formation and disposition of (E)- and (Z)-10-hydroxynortriptyline.

Authors:  E Nusser; K Nill; U Breyer-Pfaff
Journal:  Drug Metab Dispos       Date:  1988 May-Jun       Impact factor: 3.922

6.  Stereoselective ring oxidation of propranolol in man.

Authors:  T Walle; U K Walle; M J Wilson; T C Fagan; T E Gaffney
Journal:  Br J Clin Pharmacol       Date:  1984-11       Impact factor: 4.335

7.  Stability of phenobarbital N-glucosides: identification of hydrolysis products and kinetics of decomposition.

Authors:  F B Vest; W H Soine; R B Westkaemper; P J Soine
Journal:  Pharm Res       Date:  1989-06       Impact factor: 4.200

8.  Amobarbital metabolism in man: N-glucoside formation.

Authors:  B K Tang; W Kalow; A A Grey
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1978-07

9.  Phenotypic differences in mephenytoin pharmacokinetics in normal subjects.

Authors:  P J Wedlund; W S Aslanian; E Jacqz; C B McAllister; R A Branch; G R Wilkinson
Journal:  J Pharmacol Exp Ther       Date:  1985-09       Impact factor: 4.030

10.  Glucuronidation of the enantiomers of E-10-hydroxynortriptyline in human and rat liver microsomes.

Authors:  E Dumont; C von Bahr; T L Perry; L Bertilsson
Journal:  Pharmacol Toxicol       Date:  1987-11
View more
  5 in total

1.  Stereochemical characterization of the diastereomers of the amobarbital N-glucosides excreted in human urine.

Authors:  W H Soine; P J Soine; F C Wireko; D J Abraham
Journal:  Pharm Res       Date:  1990-08       Impact factor: 4.200

2.  Initial studies on the N-glucosylation of phenobarbital by mouse liver microsomes using a radiochemical high-performance liquid chromatographic (HPLC) method.

Authors:  W H Soine; H Safi; R B Westkaemper
Journal:  Pharm Res       Date:  1992-05       Impact factor: 4.200

3.  Identification of the diastereomers of pentobarbital N-glucosides excreted in human urine.

Authors:  W H Soine; P J Soine; T M England; R M Graham; G Capps
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

4.  Phenobarbital N-glucosylation by human liver microsomes.

Authors:  Sheela G Paibir; William H Soine; Diana F Thomas; Robert A Fisher
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2004 Jan-Mar       Impact factor: 2.441

5.  Urinary excretion of phenobarbitone and its metabolites in chronically treated patients.

Authors:  I Bernus; R G Dickinson; W D Hooper; M J Eadie
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.